Latebreakers: Bill to give FDA more powers advances in Congress
At press time, the Senate has passed the Food & Drug Administration Revitalization Act (S. 1082), which gives the FDA more powers to require manufacturers to conduct postmarketing studies to improve patient safety.
At press time, the Senate has passed the Food & Drug Administration Revitalization Act (S. 1082), which gives the FDA more powers to require manufacturers to conduct postmarketing studies to improve patient safety. The bill also reauthorizes the Prescription Drug User Fee Act so that the agency has the financial resources to review drug applications expeditiously. The bill now goes to the House for consideration.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
